Clinical trial / 2010
Oral aloe vera did not alter electrocardiographic or blood pressure measurements in healthy adults
In a double-blind, randomized crossover trial, 16 healthy adults (mean age 25 ± 5 years) received 1,200 mg of oral aloe vera powder or placebo. Maximum post-treatment Q-Tc intervals were 422 ± 17 milliseconds with aloe vera and 419 ± 17 milliseconds with placebo, with no significant differences between groups across an 8-hour monitoring period. Similarly, no significant differences appeared in P-R intervals, QRS duration, or systolic and diastolic blood pressure.
- Study type
- Randomized crossover trial
- Who was studied
- 16 healthy adults
- What was measured
- Electrocardiographic parameters and blood pressure
THE PAPER
Effects of oral Aloe vera on electrocardiographic and blood pressure measurements.
Shah SA, DiTullio P, Azadi M, Shapiro RJ, Eid TJ, Snyder JA. Am J Health Syst Pharm, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.